En su momento aventuramos las consecuencias que la muerte trágica de Adolf Merckle traería para esta compañía del grupo. Ahora las sospechas se confirman. La familia Merckle gestiona su venta y Sanofi se pone en cola...
Sanofi-Aventis SA of France may be among potential buyers for Mepha, said three of the people, who didn’t want to be identified because the information isn’t public. Financial investors as well as pharmaceutical companies will be asked to submit offers, two of the people said.
Mepha, which makes lower-priced copies of branded medicines to fight hypertension and cancer, may be sold before Ratiopharm GmbH, a larger generic-drug maker also being divested by the Merckles, the people said. Ludwig Merckle is selling pharmaceutical, machinery and cement assets after his father Adolf, who committed suicide in January, amassed debt and lost money on wrong-way bets on the stock market last year.
.../...
Fill Gaps
Sanofi Chief Executive Officer Chris Viehbacher has said that growth in generics is one of the company’s priorities. The French drugmaker has risen to eighth in the global generic-drug market ranking this year following its purchase of Zentiva NV of the Czech Republic, Brazil’s Medley SA and Laboratorios Kendrick of Mexico, according to a company presentation in April.
Más...Ver tambien...
Ver anterior
Entradas
No hay comentarios:
Publicar un comentario